126 related articles for article (PubMed ID: 37010064)
1. Postoperative inflammatory markers predict survival in patients after McKeown esophagectomy for esophageal cancer.
Takahashi K; Masuda T; Ishikawa Y; Tanishima Y; Kurogochi T; Yuda M; Tanaka Y; Matsumoto A; Yano F; Eto K
J Surg Oncol; 2023 Aug; 128(2):196-206. PubMed ID: 37010064
[TBL] [Abstract][Full Text] [Related]
2. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer.
Sharaiha RZ; Halazun KJ; Mirza F; Port JL; Lee PC; Neugut AI; Altorki NK; Abrams JA
Ann Surg Oncol; 2011 Nov; 18(12):3362-9. PubMed ID: 21547702
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P
World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784
[TBL] [Abstract][Full Text] [Related]
4. The Preoperative Neutrophil-To-Lymphocyte Ratio Is a Novel Immune Parameter for the Prognosis of Esophageal Basaloid Squamous Cell Carcinoma.
Xiao Q; Zhang B; Deng X; Wu J; Wang H; Wang Y; Wang W
PLoS One; 2016; 11(12):e0168299. PubMed ID: 27959959
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Preoperative Systemic Immunoinflammatory Measures in Patients with Esophageal Cancer.
Ishibashi Y; Tsujimoto H; Hiraki S; Kumano I; Yaguchi Y; Horiguchi H; Nomura S; Ito N; Shinto E; Aosasa S; Yamamoto J; Ueno H
Ann Surg Oncol; 2018 Oct; 25(11):3288-3299. PubMed ID: 30019304
[TBL] [Abstract][Full Text] [Related]
6. A Novel Systemic Inflammatory Score Combined With Immunoinflammatory Markers Accurately Reflects Prognosis in Patients With Esophageal Cancer.
Suzuki T; Ishibashi Y; Tsujimoto H; Nomura S; Kouzu K; Itazaki Y; Sugihara T; Harada M; Ito N; Sugasawa H; Kishi Y; Ueno H
In Vivo; 2020; 34(6):3705-3711. PubMed ID: 33144487
[TBL] [Abstract][Full Text] [Related]
7. Correlation Between Immunoinflammatory Measures and Periostin Expression in Esophageal Squamous Cell Carcinoma: A Single-Center, Retrospective Cohort Study.
Ishibashi Y; Tsujimoto H; Einama T; Mochizuki S; Kouzu K; Nomura S; Ito N; Harada M; Sugasawa H; Shinto E; Kishi Y; Ueno H
Ann Surg Oncol; 2021 Feb; 28(2):1228-1237. PubMed ID: 32613365
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of preoperative inflammatory response biomarkers in patients with esophageal cancer who undergo a curative thoracoscopic esophagectomy.
Hirahara N; Matsubara T; Mizota Y; Ishibashi S; Tajima Y
BMC Surg; 2016 Sep; 16(1):66. PubMed ID: 27650456
[TBL] [Abstract][Full Text] [Related]
9. Impact of inflammation-based prognostic score on survival after curative thoracoscopic esophagectomy for esophageal cancer.
Hirahara N; Matsubara T; Hayashi H; Takai K; Fujii Y; Tajima Y
Eur J Surg Oncol; 2015 Oct; 41(10):1308-15. PubMed ID: 26235238
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of the neutrophil-to-lymphocyte ratio for overall and disease-free survival in patients with surgically treated esophageal squamous cell carcinoma.
Jung J; Park SY; Park SJ; Park J
Tumour Biol; 2016 Jun; 37(6):7149-54. PubMed ID: 26662960
[TBL] [Abstract][Full Text] [Related]
11. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
Fu X; Li T; Dai Y; Li J
BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297
[TBL] [Abstract][Full Text] [Related]
12. Elevated preoperative neutrophil-to-lymphocytes ratio predicts poor prognosis after esophagectomy in T1 esophageal cancer.
Nakamura K; Yoshida N; Baba Y; Kosumi K; Uchihara T; Kiyozumi Y; Ohuchi M; Ishimoto T; Iwatsuki M; Sakamoto Y; Watanabe M; Baba H
Int J Clin Oncol; 2017 Jun; 22(3):469-475. PubMed ID: 28097441
[TBL] [Abstract][Full Text] [Related]
13. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.
Toyokawa T; Kubo N; Tamura T; Sakurai K; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M
BMC Cancer; 2016 Sep; 16(1):722. PubMed ID: 27599460
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of preoperative inflammatory response biomarkers in patients undergoing curative thoracoscopic esophagectomy for esophageal squamous cell carcinoma.
Hirahara N; Matsubara T; Kawahara D; Nakada S; Ishibashi S; Tajima Y
Eur J Surg Oncol; 2017 Feb; 43(2):493-501. PubMed ID: 28034501
[TBL] [Abstract][Full Text] [Related]
15. Comparative Analysis of Immunoinflammatory and Nutritional Measures in Surgically Resected Esophageal Cancer: A Single-center Retrospective Study.
Sakai M; Sohda M; Saito H; Ubukata Y; Nakazawa N; Kuriyama K; Hara K; Sano A; Ogata K; Yokobori T; Shirabe K; Saeki H
In Vivo; 2020; 34(2):881-887. PubMed ID: 32111799
[TBL] [Abstract][Full Text] [Related]
16. [The Impact of Neutrophil-Lymphocyte Ratio on the Prognosis in Patients Who Underwent Esophagectomy for Esophageal Cancer].
Muroya T; Wajima N; Ogasawara H; Yachi T; Akaishi T; Umetsu S; Wakasa Y; Yoshida T; Sato K; Mitsuhashi Y; Umemura K; Suzuki T; Tsuruta S; Hakamada K
Gan To Kagaku Ryoho; 2017 Oct; 44(10):912-914. PubMed ID: 29066693
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma.
Han LH; Jia YB; Song QX; Wang JB; Wang NN; Cheng YF
Asian Pac J Cancer Prev; 2015; 16(6):2245-50. PubMed ID: 25824745
[TBL] [Abstract][Full Text] [Related]
18. Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma.
Feng JF; Huang Y; Chen QX
World J Surg Oncol; 2014 Mar; 12():58. PubMed ID: 24641770
[TBL] [Abstract][Full Text] [Related]
19. Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy.
Ji WH; Jiang YH; Ji YL; Li B; Mao WM
Dis Esophagus; 2016 Jul; 29(5):403-11. PubMed ID: 25625421
[TBL] [Abstract][Full Text] [Related]
20. Preoperative NLR and PLR in the middle or lower ESCC patients with radical operation.
He YF; Luo HQ; Wang W; Chen J; Yao YW; Yan Y; Wu SS; Hu XX; Ke LH; Niu JY; Li HM; Ji CS; Hu B
Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26947428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
